Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has conditionally approved WELIREG® (belzutifan), Merck’s oral ...

Inc. today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Bristol Myers Squibb (BMS). "We are pleased to see Abecma expansion in the third ...

Although the age of onset and the rate of progression vary widely, clinical symptoms typically do not ... the ability to induce VEGF in response to hypoxia. Many of these mice die before or ...

Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

Advise patients to report signs and symptoms of hypoxia immediately to a healthcare provider ... With one of the largest clinical development programs across more than 30 tumor types, we strive to ...

For the average person, living at high altitude—where oxygen is sparser than at sea level—can have health benefits ranging ...

Scientists at Gladstone Institutes have developed a drug that mimics the effects of breathing low oxygen. In mice with Leigh Syndrome—the most common childhood mitochondrial disease—the HypoxyStat ...

Investigators from Shanghai, China, report responses above 90% by using levantinib and tislelizumab to treat patients with a ...

Veterans with apnea-hypopnea index scores implying no sleep apnea or severe sleep apnea had higher all-cause mortality rates ...

During an analysis, published in Clinical Microbiology Reviews ... and heart," says Dr Aggarwal. Hypoxia: Severe respiratory symptoms can lead to reduced oxygen levels, affecting vital organs ...

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced additional follow-up ...